CN113430182B - Bacterial laccase from Astrospiraceae of elephant intestinal tract and gene thereof - Google Patents
Bacterial laccase from Astrospiraceae of elephant intestinal tract and gene thereof Download PDFInfo
- Publication number
- CN113430182B CN113430182B CN202110906606.1A CN202110906606A CN113430182B CN 113430182 B CN113430182 B CN 113430182B CN 202110906606 A CN202110906606 A CN 202110906606A CN 113430182 B CN113430182 B CN 113430182B
- Authority
- CN
- China
- Prior art keywords
- laccase
- gene
- bacterial
- novel
- bacterial laccase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108010029541 Laccase Proteins 0.000 title claims abstract description 106
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 35
- 230000001580 bacterial effect Effects 0.000 title claims abstract description 32
- 210000001035 gastrointestinal tract Anatomy 0.000 title abstract description 6
- 241000406668 Loxodonta cyclotis Species 0.000 title description 5
- 241000283095 Elephas maximus Species 0.000 claims abstract description 15
- 241000894006 Bacteria Species 0.000 claims abstract description 7
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract 2
- JXDYKVIHCLTXOP-UHFFFAOYSA-N isatin Chemical compound C1=CC=C2C(=O)C(=O)NC2=C1 JXDYKVIHCLTXOP-UHFFFAOYSA-N 0.000 claims description 10
- 238000004042 decolorization Methods 0.000 claims description 9
- 239000013612 plasmid Substances 0.000 claims description 9
- 230000000968 intestinal effect Effects 0.000 claims description 8
- RGCKGOZRHPZPFP-UHFFFAOYSA-N alizarin Chemical compound C1=CC=C2C(=O)C3=C(O)C(O)=CC=C3C(=O)C2=C1 RGCKGOZRHPZPFP-UHFFFAOYSA-N 0.000 claims description 7
- 239000013078 crystal Substances 0.000 claims description 6
- 239000002773 nucleotide Substances 0.000 claims description 3
- 125000003729 nucleotide group Chemical group 0.000 claims description 3
- 238000005516 engineering process Methods 0.000 abstract description 9
- 241000233866 Fungi Species 0.000 abstract description 6
- 239000010949 copper Substances 0.000 abstract description 4
- 235000013824 polyphenols Nutrition 0.000 abstract description 4
- 229910052802 copper Inorganic materials 0.000 abstract description 3
- 108090000790 Enzymes Proteins 0.000 description 35
- 102000004190 Enzymes Human genes 0.000 description 31
- 230000000694 effects Effects 0.000 description 27
- 238000006243 chemical reaction Methods 0.000 description 12
- 244000063299 Bacillus subtilis Species 0.000 description 11
- 235000014469 Bacillus subtilis Nutrition 0.000 description 11
- 239000000975 dye Substances 0.000 description 10
- 239000000243 solution Substances 0.000 description 8
- 241001112693 Lachnospiraceae Species 0.000 description 7
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 7
- 239000000872 buffer Substances 0.000 description 7
- 238000001976 enzyme digestion Methods 0.000 description 7
- OJOBTAOGJIWAGB-UHFFFAOYSA-N acetosyringone Chemical compound COC1=CC(C(C)=O)=CC(OC)=C1O OJOBTAOGJIWAGB-UHFFFAOYSA-N 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 241000588724 Escherichia coli Species 0.000 description 4
- 150000001413 amino acids Chemical group 0.000 description 4
- 230000002255 enzymatic effect Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 238000012163 sequencing technique Methods 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 238000011144 upstream manufacturing Methods 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 238000012408 PCR amplification Methods 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 239000013613 expression plasmid Substances 0.000 description 3
- 239000013604 expression vector Substances 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000012795 verification Methods 0.000 description 3
- 239000012880 LB liquid culture medium Substances 0.000 description 2
- 102000003960 Ligases Human genes 0.000 description 2
- 108090000364 Ligases Proteins 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- SITLTJHOQZFJGG-UHFFFAOYSA-N N-L-alpha-glutamyl-L-valine Natural products CC(C)C(C(O)=O)NC(=O)C(N)CCC(O)=O SITLTJHOQZFJGG-UHFFFAOYSA-N 0.000 description 2
- KZNQNBZMBZJQJO-UHFFFAOYSA-N N-glycyl-L-proline Natural products NCC(=O)N1CCCC1C(O)=O KZNQNBZMBZJQJO-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 108091036078 conserved sequence Proteins 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 108010077515 glycylproline Proteins 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000012452 mother liquor Substances 0.000 description 2
- 239000012264 purified product Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- UCIYCBSJBQGDGM-LPEHRKFASA-N Ala-Arg-Pro Chemical compound C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@@H]1C(=O)O)N UCIYCBSJBQGDGM-LPEHRKFASA-N 0.000 description 1
- ZIBWKCRKNFYTPT-ZKWXMUAHSA-N Ala-Asn-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O ZIBWKCRKNFYTPT-ZKWXMUAHSA-N 0.000 description 1
- SMCGQGDVTPFXKB-XPUUQOCRSA-N Ala-Gly-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@H](C)N SMCGQGDVTPFXKB-XPUUQOCRSA-N 0.000 description 1
- DVJSJDDYCYSMFR-ZKWXMUAHSA-N Ala-Ile-Gly Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(O)=O DVJSJDDYCYSMFR-ZKWXMUAHSA-N 0.000 description 1
- RTZCUEHYUQZIDE-WHFBIAKZSA-N Ala-Ser-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O RTZCUEHYUQZIDE-WHFBIAKZSA-N 0.000 description 1
- PGNNQOJOEGFAOR-KWQFWETISA-N Ala-Tyr-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CC=C(O)C=C1 PGNNQOJOEGFAOR-KWQFWETISA-N 0.000 description 1
- XSLGWYYNOSUMRM-ZKWXMUAHSA-N Ala-Val-Asn Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O XSLGWYYNOSUMRM-ZKWXMUAHSA-N 0.000 description 1
- CLOMBHBBUKAUBP-LSJOCFKGSA-N Ala-Val-His Chemical compound C[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N CLOMBHBBUKAUBP-LSJOCFKGSA-N 0.000 description 1
- WVNFNPGXYADPPO-BQBZGAKWSA-N Arg-Gly-Ser Chemical compound NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O WVNFNPGXYADPPO-BQBZGAKWSA-N 0.000 description 1
- NKNILFJYKKHBKE-WPRPVWTQSA-N Arg-Gly-Val Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O NKNILFJYKKHBKE-WPRPVWTQSA-N 0.000 description 1
- UAOSDDXCTBIPCA-QXEWZRGKSA-N Arg-Ile-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CCCN=C(N)N)N UAOSDDXCTBIPCA-QXEWZRGKSA-N 0.000 description 1
- RATVAFHGEFAWDH-JYJNAYRXSA-N Arg-Phe-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CCCN=C(N)N)N RATVAFHGEFAWDH-JYJNAYRXSA-N 0.000 description 1
- LRPZJPMQGKGHSG-XGEHTFHBSA-N Arg-Ser-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCN=C(N)N)N)O LRPZJPMQGKGHSG-XGEHTFHBSA-N 0.000 description 1
- IZSMEUDYADKZTJ-KJEVXHAQSA-N Arg-Tyr-Thr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O IZSMEUDYADKZTJ-KJEVXHAQSA-N 0.000 description 1
- OOWSBIOUKIUWLO-RCOVLWMOSA-N Asn-Gly-Val Chemical compound [H]N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O OOWSBIOUKIUWLO-RCOVLWMOSA-N 0.000 description 1
- XVBDDUPJVQXDSI-PEFMBERDSA-N Asn-Ile-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CC(=O)N)N XVBDDUPJVQXDSI-PEFMBERDSA-N 0.000 description 1
- WIDVAWAQBRAKTI-YUMQZZPRSA-N Asn-Leu-Gly Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O WIDVAWAQBRAKTI-YUMQZZPRSA-N 0.000 description 1
- YWLDTBBUHZJQHW-KKUMJFAQSA-N Asp-Lys-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)N YWLDTBBUHZJQHW-KKUMJFAQSA-N 0.000 description 1
- QSFHZPQUAAQHAQ-CIUDSAMLSA-N Asp-Ser-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O QSFHZPQUAAQHAQ-CIUDSAMLSA-N 0.000 description 1
- BYLPQJAWXJWUCJ-YDHLFZDLSA-N Asp-Tyr-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(O)=O BYLPQJAWXJWUCJ-YDHLFZDLSA-N 0.000 description 1
- 108010031396 Catechol oxidase Proteins 0.000 description 1
- 102000030523 Catechol oxidase Human genes 0.000 description 1
- YMBAVNPKBWHDAW-CIUDSAMLSA-N Cys-Asp-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CS)N YMBAVNPKBWHDAW-CIUDSAMLSA-N 0.000 description 1
- DZSICRGTVPDCRN-YUMQZZPRSA-N Cys-Gly-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CS)N DZSICRGTVPDCRN-YUMQZZPRSA-N 0.000 description 1
- JDHMXPSXWMPYQZ-AAEUAGOBSA-N Cys-Gly-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CS)N JDHMXPSXWMPYQZ-AAEUAGOBSA-N 0.000 description 1
- BBQIWFFTTQTNOC-AVGNSLFASA-N Cys-Phe-Gln Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CS)N BBQIWFFTTQTNOC-AVGNSLFASA-N 0.000 description 1
- QQAYIVHVRFJICE-AEJSXWLSSA-N Cys-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CS)N QQAYIVHVRFJICE-AEJSXWLSSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- QZQYITIKPAUDGN-GVXVVHGQSA-N Gln-Val-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CCC(=O)N)N QZQYITIKPAUDGN-GVXVVHGQSA-N 0.000 description 1
- ZOXBSICWUDAOHX-GUBZILKMSA-N Glu-Asn-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCC(O)=O ZOXBSICWUDAOHX-GUBZILKMSA-N 0.000 description 1
- UENPHLAAKDPZQY-XKBZYTNZSA-N Glu-Cys-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)O)N)O UENPHLAAKDPZQY-XKBZYTNZSA-N 0.000 description 1
- ZJFNRQHUIHKZJF-GUBZILKMSA-N Glu-His-Asp Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(O)=O)C(O)=O ZJFNRQHUIHKZJF-GUBZILKMSA-N 0.000 description 1
- LURCIJSJAKFCRO-QWRGUYRKSA-N Gly-Asn-Tyr Chemical compound [H]NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O LURCIJSJAKFCRO-QWRGUYRKSA-N 0.000 description 1
- FUTAPPOITCCWTH-WHFBIAKZSA-N Gly-Asp-Asp Chemical compound [H]NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O FUTAPPOITCCWTH-WHFBIAKZSA-N 0.000 description 1
- FGPLUIQCSKGLTI-WDSKDSINSA-N Gly-Ser-Glu Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(O)=O FGPLUIQCSKGLTI-WDSKDSINSA-N 0.000 description 1
- SBVMXEZQJVUARN-XPUUQOCRSA-N Gly-Val-Ser Chemical compound NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O SBVMXEZQJVUARN-XPUUQOCRSA-N 0.000 description 1
- JBCLFWXMTIKCCB-UHFFFAOYSA-N H-Gly-Phe-OH Natural products NCC(=O)NC(C(O)=O)CC1=CC=CC=C1 JBCLFWXMTIKCCB-UHFFFAOYSA-N 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- HAPWZEVRQYGLSG-IUCAKERBSA-N His-Gly-Glu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O HAPWZEVRQYGLSG-IUCAKERBSA-N 0.000 description 1
- QIHJTGSVGIPHIW-QSFUFRPTSA-N Ile-Asn-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)O)N QIHJTGSVGIPHIW-QSFUFRPTSA-N 0.000 description 1
- DFJJAVZIHDFOGQ-MNXVOIDGSA-N Ile-Glu-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N DFJJAVZIHDFOGQ-MNXVOIDGSA-N 0.000 description 1
- WSSGUVAKYCQSCT-XUXIUFHCSA-N Ile-Met-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)O)N WSSGUVAKYCQSCT-XUXIUFHCSA-N 0.000 description 1
- ZNOBVZFCHNHKHA-KBIXCLLPSA-N Ile-Ser-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N ZNOBVZFCHNHKHA-KBIXCLLPSA-N 0.000 description 1
- SITWEMZOJNKJCH-UHFFFAOYSA-N L-alanine-L-arginine Natural products CC(N)C(=O)NC(C(O)=O)CCCNC(N)=N SITWEMZOJNKJCH-UHFFFAOYSA-N 0.000 description 1
- JKGHDYGZRDWHGA-SRVKXCTJSA-N Leu-Asn-Leu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O JKGHDYGZRDWHGA-SRVKXCTJSA-N 0.000 description 1
- HFBCHNRFRYLZNV-GUBZILKMSA-N Leu-Glu-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O HFBCHNRFRYLZNV-GUBZILKMSA-N 0.000 description 1
- OXRLYTYUXAQTHP-YUMQZZPRSA-N Leu-Gly-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(O)=O OXRLYTYUXAQTHP-YUMQZZPRSA-N 0.000 description 1
- QNBVTHNJGCOVFA-AVGNSLFASA-N Leu-Leu-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCC(O)=O QNBVTHNJGCOVFA-AVGNSLFASA-N 0.000 description 1
- RDFIVFHPOSOXMW-ACRUOGEOSA-N Leu-Tyr-Phe Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O RDFIVFHPOSOXMW-ACRUOGEOSA-N 0.000 description 1
- ZXEUFAVXODIPHC-GUBZILKMSA-N Lys-Glu-Asn Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O ZXEUFAVXODIPHC-GUBZILKMSA-N 0.000 description 1
- WGLAORUKDGRINI-WDCWCFNPSA-N Lys-Glu-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O WGLAORUKDGRINI-WDCWCFNPSA-N 0.000 description 1
- QOJDBRUCOXQSSK-AJNGGQMLSA-N Lys-Ile-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(O)=O QOJDBRUCOXQSSK-AJNGGQMLSA-N 0.000 description 1
- AIRZWUMAHCDDHR-KKUMJFAQSA-N Lys-Leu-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O AIRZWUMAHCDDHR-KKUMJFAQSA-N 0.000 description 1
- WLXGMVVHTIUPHE-ULQDDVLXSA-N Lys-Phe-Val Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(O)=O WLXGMVVHTIUPHE-ULQDDVLXSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- ONGCSGVHCSAATF-CIUDSAMLSA-N Met-Ala-Glu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCC(O)=O ONGCSGVHCSAATF-CIUDSAMLSA-N 0.000 description 1
- SBSIKVMCCJUCBZ-GUBZILKMSA-N Met-Asn-Arg Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(O)=O)CCCNC(N)=N SBSIKVMCCJUCBZ-GUBZILKMSA-N 0.000 description 1
- IVCPHARVJUYDPA-FXQIFTODSA-N Met-Asn-Asp Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)N IVCPHARVJUYDPA-FXQIFTODSA-N 0.000 description 1
- CFRRIZLGFGJEDB-SRVKXCTJSA-N Met-His-Gln Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(N)=O)C(O)=O CFRRIZLGFGJEDB-SRVKXCTJSA-N 0.000 description 1
- HZVXPUHLTZRQEL-UWVGGRQHSA-N Met-Leu-Gly Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O HZVXPUHLTZRQEL-UWVGGRQHSA-N 0.000 description 1
- GMMLGMFBYCFCCX-KZVJFYERSA-N Met-Thr-Ala Chemical compound CSCC[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O GMMLGMFBYCFCCX-KZVJFYERSA-N 0.000 description 1
- CQRGINSEMFBACV-WPRPVWTQSA-N Met-Val-Gly Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O CQRGINSEMFBACV-WPRPVWTQSA-N 0.000 description 1
- 102000043368 Multicopper oxidase Human genes 0.000 description 1
- 108010065395 Neuropep-1 Proteins 0.000 description 1
- RTUWVJVJSMOGPL-KKUMJFAQSA-N Phe-Met-Glu Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)N RTUWVJVJSMOGPL-KKUMJFAQSA-N 0.000 description 1
- IAOZOFPONWDXNT-IXOXFDKPSA-N Phe-Ser-Thr Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O IAOZOFPONWDXNT-IXOXFDKPSA-N 0.000 description 1
- FZHBZMDRDASUHN-NAKRPEOUSA-N Pro-Ala-Ile Chemical compound CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1)C(O)=O FZHBZMDRDASUHN-NAKRPEOUSA-N 0.000 description 1
- XKHCJJPNXFBADI-DCAQKATOSA-N Pro-Asp-Lys Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O XKHCJJPNXFBADI-DCAQKATOSA-N 0.000 description 1
- FFSLAIOXRMOFIZ-GJZGRUSLSA-N Pro-Gly-Trp Chemical compound N([C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)O)C(=O)CNC(=O)[C@@H]1CCCN1 FFSLAIOXRMOFIZ-GJZGRUSLSA-N 0.000 description 1
- VWXGFAIZUQBBBG-UWVGGRQHSA-N Pro-His-Gly Chemical compound C([C@@H](C(=O)NCC(=O)[O-])NC(=O)[C@H]1[NH2+]CCC1)C1=CN=CN1 VWXGFAIZUQBBBG-UWVGGRQHSA-N 0.000 description 1
- VLMIUSLQONKLDV-HEIBUPTGSA-N Ser-Thr-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O VLMIUSLQONKLDV-HEIBUPTGSA-N 0.000 description 1
- NJEMRSFGDNECGF-GCJQMDKQSA-N Thr-Ala-Asp Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC(O)=O NJEMRSFGDNECGF-GCJQMDKQSA-N 0.000 description 1
- LKEKWDJCJSPXNI-IRIUXVKKSA-N Thr-Glu-Tyr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 LKEKWDJCJSPXNI-IRIUXVKKSA-N 0.000 description 1
- NIEWSKWFURSECR-FOHZUACHSA-N Thr-Gly-Asp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O NIEWSKWFURSECR-FOHZUACHSA-N 0.000 description 1
- IMULJHHGAUZZFE-MBLNEYKQSA-N Thr-Gly-Ile Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(O)=O IMULJHHGAUZZFE-MBLNEYKQSA-N 0.000 description 1
- IQPWNQRRAJHOKV-KATARQTJSA-N Thr-Ser-Lys Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCCN IQPWNQRRAJHOKV-KATARQTJSA-N 0.000 description 1
- WPSKTVVMQCXPRO-BWBBJGPYSA-N Thr-Ser-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O WPSKTVVMQCXPRO-BWBBJGPYSA-N 0.000 description 1
- QNMIVTOQXUSGLN-SZMVWBNQSA-N Trp-Arg-Arg Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O)=CNC2=C1 QNMIVTOQXUSGLN-SZMVWBNQSA-N 0.000 description 1
- VDCGPCSLAJAKBB-XIRDDKMYSA-N Trp-Ser-His Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC3=CN=CN3)C(=O)O)N VDCGPCSLAJAKBB-XIRDDKMYSA-N 0.000 description 1
- FZSPNKUFROZBSG-ZKWXMUAHSA-N Val-Ala-Asp Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC(O)=O FZSPNKUFROZBSG-ZKWXMUAHSA-N 0.000 description 1
- CPTQYHDSVGVGDZ-UKJIMTQDSA-N Val-Gln-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](C(C)C)N CPTQYHDSVGVGDZ-UKJIMTQDSA-N 0.000 description 1
- UKEVLVBHRKWECS-LSJOCFKGSA-N Val-Ile-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](C(C)C)N UKEVLVBHRKWECS-LSJOCFKGSA-N 0.000 description 1
- SDUBQHUJJWQTEU-XUXIUFHCSA-N Val-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](C(C)C)N SDUBQHUJJWQTEU-XUXIUFHCSA-N 0.000 description 1
- GVJUTBOZZBTBIG-AVGNSLFASA-N Val-Lys-Arg Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N GVJUTBOZZBTBIG-AVGNSLFASA-N 0.000 description 1
- AJNUKMZFHXUBMK-GUBZILKMSA-N Val-Ser-Arg Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N AJNUKMZFHXUBMK-GUBZILKMSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 108010086434 alanyl-seryl-glycine Proteins 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 108010013835 arginine glutamate Proteins 0.000 description 1
- 108010072041 arginyl-glycyl-aspartic acid Proteins 0.000 description 1
- 108010069926 arginyl-glycyl-serine Proteins 0.000 description 1
- 108010068380 arginylarginine Proteins 0.000 description 1
- 150000001491 aromatic compounds Chemical class 0.000 description 1
- 108010040443 aspartyl-aspartic acid Proteins 0.000 description 1
- 108010038633 aspartylglutamate Proteins 0.000 description 1
- 238000009412 basement excavation Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- QKUSRAKPUWQSJS-UHFFFAOYSA-N diazanium 3-ethyl-2H-1,3-benzothiazole-6-sulfonate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)C1=CC=C2N(CC)CSC2=C1.[O-]S(=O)(=O)C1=CC=C2N(CC)CSC2=C1 QKUSRAKPUWQSJS-UHFFFAOYSA-N 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 229910001882 dioxygen Inorganic materials 0.000 description 1
- FSXRLASFHBWESK-UHFFFAOYSA-N dipeptide phenylalanyl-tyrosine Natural products C=1C=C(O)C=CC=1CC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FSXRLASFHBWESK-UHFFFAOYSA-N 0.000 description 1
- CBMPTFJVXNIWHP-UHFFFAOYSA-L disodium;hydrogen phosphate;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound [Na+].[Na+].OP([O-])([O-])=O.OC(=O)CC(O)(C(O)=O)CC(O)=O CBMPTFJVXNIWHP-UHFFFAOYSA-L 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 108010063718 gamma-glutamylaspartic acid Proteins 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000005227 gel permeation chromatography Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 108010055341 glutamyl-glutamic acid Proteins 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 108010027668 glycyl-alanyl-valine Proteins 0.000 description 1
- 108010078326 glycyl-glycyl-valine Proteins 0.000 description 1
- 108010008671 glycyl-tryptophyl-methionine Proteins 0.000 description 1
- 108010045383 histidyl-glycyl-glutamic acid Proteins 0.000 description 1
- 108010036413 histidylglycine Proteins 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 108010027338 isoleucylcysteine Proteins 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 108010085203 methionylmethionine Proteins 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 108700020788 multicopper oxidase Proteins 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 108010053725 prolylvaline Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 108010072986 threonyl-seryl-lysine Proteins 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0055—Oxidoreductases (1.) acting on diphenols and related substances as donors (1.10)
- C12N9/0057—Oxidoreductases (1.) acting on diphenols and related substances as donors (1.10) with oxygen as acceptor (1.10.3)
- C12N9/0061—Laccase (1.10.3.2)
-
- A—HUMAN NECESSITIES
- A62—LIFE-SAVING; FIRE-FIGHTING
- A62D—CHEMICAL MEANS FOR EXTINGUISHING FIRES OR FOR COMBATING OR PROTECTING AGAINST HARMFUL CHEMICAL AGENTS; CHEMICAL MATERIALS FOR USE IN BREATHING APPARATUS
- A62D3/00—Processes for making harmful chemical substances harmless or less harmful, by effecting a chemical change in the substances
- A62D3/02—Processes for making harmful chemical substances harmless or less harmful, by effecting a chemical change in the substances by biological methods, i.e. processes using enzymes or microorganisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y110/00—Oxidoreductases acting on diphenols and related substances as donors (1.10)
- C12Y110/03—Oxidoreductases acting on diphenols and related substances as donors (1.10) with an oxygen as acceptor (1.10.3)
- C12Y110/03002—Laccase (1.10.3.2)
-
- A—HUMAN NECESSITIES
- A62—LIFE-SAVING; FIRE-FIGHTING
- A62D—CHEMICAL MEANS FOR EXTINGUISHING FIRES OR FOR COMBATING OR PROTECTING AGAINST HARMFUL CHEMICAL AGENTS; CHEMICAL MATERIALS FOR USE IN BREATHING APPARATUS
- A62D2101/00—Harmful chemical substances made harmless, or less harmful, by effecting chemical change
- A62D2101/40—Inorganic substances
- A62D2101/45—Inorganic substances containing nitrogen or phosphorus
-
- A—HUMAN NECESSITIES
- A62—LIFE-SAVING; FIRE-FIGHTING
- A62D—CHEMICAL MEANS FOR EXTINGUISHING FIRES OR FOR COMBATING OR PROTECTING AGAINST HARMFUL CHEMICAL AGENTS; CHEMICAL MATERIALS FOR USE IN BREATHING APPARATUS
- A62D2101/00—Harmful chemical substances made harmless, or less harmful, by effecting chemical change
- A62D2101/40—Inorganic substances
- A62D2101/47—Inorganic substances containing oxygen, sulfur, selenium or tellurium, i.e. chalcogen
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Business, Economics & Management (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Emergency Management (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention discloses a bacterial laccase from Astrospiraceae of Asian elephant intestinal tract and a gene thereof, wherein the amino acid sequence of the bacterial laccase is shown as SEQIDNO.1, the coding gene is shown as SEQIDNO.2, the genome of a strain of bacteria of NK4A136 genus of the Astrospiraceae is obtained by assembling by using a metagenome component box technology, the gene containing multi-copper polyphenol oxidoreductase laccase is annotated by InterPro and Pfam databases, and the bacterial laccase is prepared by a gene engineering technology. Compared with laccase from fungi, the bacterial laccase has better pH stability and temperature stability.
Description
Technical Field
The invention belongs to the technical field of enzyme genetic engineering, and relates to bacterial laccase from Astrospiraceae of elephant intestinal tract and a gene thereof.
Background
Laccases (laccanase, EC 1.10.3.2), also known as phenolase, polyphenol oxidase, belong to the class of multicopper oxidases, which are capable of oxidizing a variety of aromatic compounds, ultimately reducing molecular oxygen to water. Therefore, laccase is a green catalyst with important application value.
Laccase is widely distributed in fungi and bacteriaBacteria, insects, and animals and plants. Compared with laccase from animals and plants, the microbial laccase has richer sources. The laccase from fungi has higher activity under the conditions of pH 4-6 and 30-55 ℃, and the industrial application usually needs high temperature and strong alkali environment, so that the laccase is limited in application and higher in cost. And the long growth period of the fungi has strict requirements on the culture medium, so that the fermentation tank is easily damaged mechanically, and the application of the fungal laccase in the industry is seriously influenced due to the problems. The bacterial laccase does not need glycosylation modification, usually exists in a monomer proteosome form, has wide pH application range and good thermal stability, and has Cu 2+ Resistance, and the like. These are of great significance for the broader application of laccases. At present, the excavation of bacterial laccase gene resources is less, and novel bacterial laccase with high activity and high stability needs to be further explored.
With the development of the second generation sequencing technology and the combination of metagenomic analysis means, the method can successfully avoid the difficult problem of the traditional microorganism pure culture technology in the aspect of digging the functional enzyme genes of the microorganisms, can quickly discover a large amount of functional enzyme genes in a short time, and improves the functional enzyme genes
The universality and the effectiveness of the screening greatly promote the improvement of the cloning efficiency of the functional enzyme gene, and provide a new research strategy for searching and discovering novel laccase genes.
Disclosure of Invention
The invention aims to overcome and avoid the defects of laccase in industrial production application, and provides a novel bacterial laccase coding gene from Asian elephant intestinal uncultured lachnospiraceae and an engineering strain for expressing the novel bacterial laccase gene.
According to the invention, the encoding gene of the novel laccase is derived from Asian elephant intestinal microorganism metagenome, a genome (the integrity is 96.44% and the pollution rate is 0) of a strain of uncultured lachnospiraceae NK4A136 bacteria is obtained by applying a Binning (Binning) technology, the genes (IPR 003730 and PF 02578.16) containing multi-copper polyphenol oxidoreductase laccase genes are annotated by InterPro and Pfam databases, and the highest consistency of the amino acid sequence of the laccase gene and the existing laccase amino acid sequence of the NR database is about 52%. The novel laccase coding gene is cloned and expressed in a bacillus subtilis expression system, and a bacillus subtilis high-stability laccase recombinant strain is obtained.
In order to achieve the technical purpose, the invention is specifically realized by the following technical scheme:
a bacterial laccase from Astrospiraceae is disclosed, wherein the amino acid sequence of the bacterial laccase is shown in SEQ ID NO. 1.
When the enzymatic properties of the novel laccase are determined by using a substrate 2,2' -biazonitrogen-di (3-ethyl-benzothiazole-6-sulfonic acid) diammonium salt (ABTS), the optimal action temperature is 70 ℃, and the optimal action pH is 5.
The pH stability and the thermal stability of the novel laccase are determined by using a substrate ABTS, and the results show that: has good stability within the pH range of 5-6 at 60 ℃, and has better pH stability and thermal stability than laccase from fungi as a novel laccase from uncultured lachnospiraceae bacteria in intestinal tracts of Asian elephants.
The encoding gene of the bacterial laccase is also prepared within the protection range of the invention, and the nucleotide sequence of the encoding gene is shown in SEQ ID NO.2.
In another aspect of the invention, the gene encoding the bacterial laccase is inserted into an expression vector such that its nucleotide sequence is linked to an expression control sequence. A recombinant vector comprising the encoding gene is provided.
As a preferred embodiment of the invention, the coding gene of the bacterial laccase is connected with an expression vector pBE-S to obtain a recombinant Escherichia coli expression plasmid pBE-S-Laac2.
More preferably, the host cell used to express the bacterial laccase is e.
In another aspect of the invention, there is also provided a recombinant strain comprising a gene encoding said bacterial laccase.
Preferably, the recombinant strain is Bacillus subtilis, and more preferably, the recombinant strain is WB600/pBE-S-Lacc2.
In another aspect of the invention, there is provided a method for preparing the above novel bacterial laccase, comprising the following steps:
1) Taking Asian elephant intestinal metagenome DNA as a template, assembling genes for encoding laccase in the uncultured lacospiraceae bacterial genome according to metagenome binning technology, analyzing conserved sequences of the genes, designing encoding gene amplification primers Pf and Pr of the laccase, and obtaining a target laccase encoding gene lacc2 through PCR amplification;
an upstream primer Pf: CAATTCATGAATGATGATATGACAGCAG,
and a downstream primer Pr: gtcgacctadtctagcaaggcatgataac;
2) Carrying out EcoRI and SalI double enzyme digestion on a laccase coding gene lacc2 and an expression vector pBE-S, connecting T4 ligase, and then transforming to a cloning host E.coli DH5 alpha, and obtaining a recombinant plasmid pBE-S-lac 2 after colony PCR, enzyme digestion and sequencing verification are correct;
3) Transforming the recombinant plasmid pBE-S-lac 2 into a host bacillus subtilis WB600 and successfully expressing to obtain a recombinant strain for producing the novel laccase with high stability;
4) And a novel laccase Lacc2 with high yield and high stability is obtained by optimizing a fermentation process.
In another aspect of the invention, the laccase Lacc2 is used for decoloring crystal violet, alizarin red, isatin and active black 5.
The decolorization rates of the novel laccase Lacc2 to crystal violet, alizarin red, isatin and active black 5 within 6h are respectively 80.8%, 81.6%, 68.5% and 45.85% under the condition of no mediator; after mediator acetosyringone is added into the system, the decolorization rate of the novel laccase Lacc2 to active black 5 is improved to 84.95% within 6 h.
The beneficial effects of the invention are as follows:
the invention obtains a genome (with the integrity of 96.44% and the pollution rate of 0%) of a bacterium of the genus NK4A136 of the family lachnospiraceae without culture by assembling through a metagenome binning technology, annotates a multi-copper polyphenol oxidoreductase laccase gene by an InterPro and Pfam database, and obtains the bacterial laccase Lacc2 by preparing through a gene engineering technology. Compared with laccase from fungi, the bacterial laccase Lacc2 has good stability at 70 ℃ within the pH range of 5-6, and has better pH stability and temperature stability.
Drawings
FIG. 1 is a PCR amplification verification electrophoretogram of the novel laccase coding gene of the invention;
FIG. 2 is an enzyme-cutting electrophoresis diagram of recombinant plasmid pBE-S-lac 2 of the present invention;
FIG. 3 is the optimum temperature curve of Lacc2 for the laccase of the present invention;
FIG. 4 is the pH curve for optimum action of the novel laccase Lacc2 of the present invention;
FIG. 5 shows the decolorizing effect of the novel laccase Lacc2 of the present invention on 4 dyes, wherein A is the decolorizing effect of the novel laccase Lacc2 on 4 dyes under the condition of no mediator, and B is the decolorizing effect of the novel laccase Lacc2 on 4 dyes under the condition of mediator.
Detailed Description
The technical solutions of the present invention will be described clearly and completely with reference to specific embodiments of the present invention, and it should be understood that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be obtained by a person skilled in the art without making any creative effort based on the embodiments in the present invention, belong to the protection scope of the present invention.
The Asian elephant intestinal metagenome sequencing original data used by the invention is stored in a genome sequence archive library of a big data center of China academy of sciences, and the accession number is CRA003369.
Example 1 obtaining of laccase Gene from novel bacteria of the family Astrospiraceae uncultured in the intestinal tract of elephant Asian elephant
1. The novel laccase coding gene is derived from an Asian elephant fresh excrement metagenome stored in a laboratory, and the metagenome DNA of the Asian elephant fresh excrement metagenome is extracted by using a Kit (QIAamp DNA Stool Mini Kit), wherein the extraction steps of the Asian elephant fresh excrement metagenome DNA are as follows:
1) Weighing 0.2g of Asian elephant excrement into a sterilized centrifuge tube;
2) Adding 1.4mL buffer ASL, continuously swirling for several minutes until the mixture is fully mixed, incubating at 70 ℃ for 5min, and then swirling and mixing for 15s;
3) Centrifuging at 20,000g for 1min to remove fecal impurities, and collecting the supernatant to a new centrifuge tube;
4) Adding 1 inhibitor Tablet, mixing for 1min, standing at room temperature for 1min to adsorb the inhibitor onto the inhibitor matrix, and centrifuging at 20,000g for 3min;
5) Taking the supernatant to a new centrifugal tube, and centrifuging for 1 time again in the same way as in 4);
6) Sucking the supernatant into a new centrifuge tube added with 15 mu L of protease K, adding 200 mu L of buffer AL, fully and uniformly mixing, and then incubating at 70 ℃ for 10min;
7) Adding 200 μ L of anhydrous ethanol, mixing well, transferring to QIAamp adsorption column, and centrifuging for 1min at 20,000g (if the liquid does not completely pass through the column, repeating the centrifugation for 1 time);
8) Washing the column with 500. Mu.L buffer AW1 and AW2, respectively, centrifuging for 3min, and transferring the column to a new collection tube;
9) And adding a proper amount of buffer AE in the center of the adsorption column, standing at room temperature for 1min, centrifuging for 1min for elution, and allowing the obtained metagenome DNA to be used in downstream molecular biology experiments or stored at-20 ℃ for later use.
2. By a box separation (Binning) assembly technology of macrogenomics analysis, a genome (the integrity is 99.73 percent and the pollution rate is 0) of a bacterium of the genus NK4A136 of the family lacospiraceae without culture is obtained, an InterPro and Pfam database is annotated to contain a multicopper polyphenol oxidoreductase laccase gene (IPR 003730 and PF 02578.16), the result of a blast of an NR database shows that the consistency with the highest amino acid of laccase of the NR database is about 52 percent, the conserved sequence of the novel laccase is analyzed, and the amplification primers of the laccase coding gene are designed as follows:
an upstream primer Pf: CAATTCATGAATGATGATATGACAGCAG,
and a downstream primer Pr: gtcgacctadctatctagcaaggcatgataac;
the upstream and downstream primers Pf and Pr are used to amplify laccase gene expressed in Bacillus subtilis, and restriction sites EcoRI and SalI are introduced into the upstream and downstream primers, respectively.
The amplification template is Asian elephant intestinal metagenome DNA, and the PCR amplification reaction system is as follows: EX Taq 1.25. Mu.L, 10XBuffer 10. Mu.L, dNTP mix 5. Mu.L, pf and Pr each 2.5. Mu.L, DNA 5. Mu.L, ddH 2 0.75. Mu.L, total volume 100. Mu.L.
The amplification reaction conditions are as follows: 94 ℃,5min; 30s at 94 ℃; the temperature is between 55 and 61 ℃ for 30s;72 ℃ for 1min (2-4, 30 cycles); 72 ℃ for 10min;4 ℃ for 10min.
The PCR product is verified by 0.8% agarose gel electrophoresis to obtain a band of 795bp (figure 1), and the PCR product gel is recovered, then subjected to double enzyme digestion and purification recovery to obtain the novel bacterial laccase coding gene lacc2 of the Asian elephant intestinal unculture lachnospiraceae, shown as a sequence SEQ ID NO.2.
Example 2 construction of novel bacterial laccase recombinant plasmid derived from uncultured lachnospiraceae of elephant intestinal tract
1) Carrying out double digestion on the expression plasmid pBE-S by using restriction endonucleases EcoRI and SalI, carrying out double digestion on the expression plasmid pBE-S by using T4 ligase, carrying out enzyme digestion on a purified product of the pBE-S plasmid, connecting the purified product with a target gene after enzyme digestion at 16 ℃ overnight, and chemically converting the connected product to E.coli DH5 alpha.
2) Obtaining recombinant plasmid pBE-S-lacc2 after colony PCR identification, double enzyme digestion identification (figure 2) and correct sequencing;
3) A correctly verified clone of the recombinant plasmid pBE-S-lac 2 E.coli DH 5. Alpha./pBE-S-lac 2 plus 15% glycerol was stored at-80 ℃.
Example 3 construction of novel high-stability laccase recombinant bacteria of Bacillus subtilis
1) Adding 1 mu L (50 ng/. Mu.L) of pBE-S-lacc2 recombinant plasmid into the WB600 competent cells of the bacillus subtilis, and gently mixing the mixture evenly;
2) After mixing, transferring the mixture into a precooled electric rotating cup, carrying out electric shock once (3.0 kV, 3.0-4.5 ms) after ice bath for 1-1.5 min, and immediately adding 1mL of recovery culture medium (LB +0.5mol/L sorbitol +0.38mol/L mannitol) after the electric shock is finished;
3) After shaking culture at 37 ℃ for 3h, spreading the bacterial liquid on an LB plate containing Kan resistance, and culturing at 37 ℃ for about 16 h;
4) And (3) selecting positive transformants, carrying out double enzyme digestion verification, and determining to obtain the bacillus subtilis recombinant strain WB600/pBE-S-lac 2 for expressing lac 2.
Example 4 determination of laccase Activity
The determination of the enzyme activity is three parallel experiments, and the results are averaged.
Enzyme activity unit (U): the amount of laccase required to oxidize 1. Mu. Mol of ABTS in 1 min.
480. Mu.L of disodium hydrogenphosphate-citric acid buffer and 100. Mu.L of 3mmol/L ABTS were thoroughly mixed in advance, and then the mixture was subjected to water bath at 50 ℃ for 5min. 20 μ L of Lacc1 laccase solution was added quickly. OD was read at a wavelength of 420 nm.
The laccase enzyme activity has the following calculation formula:
enzyme activity (U/L) = (delta) OD ×V 1 ×n)/(Δ t ×V 2 ×ε×10 -6 )
In the formula,. DELTA. OD The difference in absorbance at the beginning and end; v 1 Is the total volume (mL) of the reaction system; n is the dilution multiple of the enzyme solution; delta t Reaction time (min); v 2 Is the volume (mL) of enzyme solution in the system; ε represents the molar digestion coefficient (L/(mol. Cm)).
pH optimum of laccase: at 50 ℃, the reaction system is placed in buffer solutions with different pH values (2.0-11.0), the enzyme activity is measured, the highest enzyme activity is 100 percent, and the optimal reaction pH value is obtained by comparison.
Optimum temperature: and (3) under the condition of the optimal reaction pH, respectively measuring the enzyme activity of the reaction system at different temperatures (30, 40, 50, 60, 70, 80, 90 and 100 ℃), and obtaining the optimal reaction temperature of the laccase by taking the highest enzyme activity as 100%.
pH stability: placing the enzyme solution in buffer solutions with different pH values, maintaining the temperature at 4 ℃ for 5h, taking the highest enzyme activity as 100%, and determining the residual enzyme activity.
And (3) measuring the thermal stability: under the condition of the optimal reaction pH, the laccase is placed under the condition of different temperature gradients (30-90 ℃) for incubation for 2 hours, and the residual enzyme activity of the Lacc1 laccase is determined by taking the highest enzyme activity as 100%.
The enzymatic properties of the novel laccase are determined by the method, and the enzymatic properties of the novel laccase are as follows:
when ABTS is used as a substrate to determine the enzymatic properties of the novel laccase, the optimal temperature is 70 ℃ (figure 3), and the optimal pH is 5 (figure 4);
the pH stability and the thermal stability of the novel laccase are determined by taking ABTS as a substrate, and the result shows that: the novel bacterial laccase has good stability within the range of pH 5-6 at 60 ℃. When the enzyme is stored for 4 days at 4 ℃ and pH =5, the residual enzyme activity reaches about 300%, and when the enzyme is stored for 4 days at 4 ℃ and pH =6.5, the residual enzyme activity reaches about 200%; when the enzyme is stored at 4 ℃ and pH =5 for 10 days, the residual enzyme activity reaches about 200%, and when the enzyme is stored at 4 ℃ and pH =6.5 for 10 days, the residual enzyme activity reaches about 200% (the enzyme activities are all determined at 70 ℃ and pH5, and the initial enzyme activity is taken as 100%).
Example 5 expression and preparation of novel laccases in recombinant strains of Bacillus subtilis
1) Selecting a Bacillus subtilis recombinant strain WB600/pBE-S-lacc2 single colony, inoculating the single colony into an LB liquid culture medium containing kanamycin, and oscillating at 37 ℃ for overnight culture;
2) Inoculating the seeds obtained by the culture in the step 1) into 50mL of LB liquid culture medium in an amount of 2%, and performing shake culture at 37 ℃ for about 48 hours;
3) Centrifuging the fermentation liquor obtained in the step 2), and collecting the supernatant to obtain a high-stability crude enzyme solution of the novel laccase;
4) Measuring the activity of crude laccase liquid enzyme (under the conditions of pH5 and 70 ℃) by using ABTS as a substrate, wherein the enzyme activity of laccase can reach 300U/mL after the novel laccase recombinant strain expressed by the bacillus subtilis is fermented, then precipitating the novel laccase by adopting a fractional salting-out method, collecting protein precipitate, dialyzing and desalting after dissolving, and then carrying out ion exchange chromatography and gel chromatography, and carrying out freeze drying to obtain the novel laccase pure enzyme powder.
Example 6 decolorization of 4 dyes and calculation of decolorization ratio by novel laccase Lacc2
The initial concentration of the alizarin is 1,000mg/L, the final concentration is 100mg/L, and the maximum absorption wavelength is 520nm; the initial concentration of the active black 5 is 400mg/L, the final concentration is 40mg/L, and the maximum absorption wavelength is 597nm; the initial concentration of the isatin is 250mg/L, the final concentration is 25mg/L, and the maximum absorption wavelength is 610nm; the initial concentration of crystal violet is 50mg/L, the final concentration is 5mg/L, and the maximum absorption wavelength is 583nm. The total volume of the medium-free decolorization reaction system is 12mL, and the medium-free decolorization reaction system comprises 1.2mL of dye mother liquor, 100 mu L of novel laccase Lacc2 crude enzyme solution and 0.2mol/L of Na with the pH value of 5 2 HPO 4 -NaHPO 4 Buffer 10.7mL. The total volume of the decolorizing reaction system with mediator is 12mL, and comprises 12 mu L of 0.1mol/L acetosyringone, 1.2mL of dye mother liquor, 100 mu L of crude enzyme solution of novel laccase Lacc2 and 0.2mol/L Na with pH value of 5 2 HPO 4 -NaHPO 4 Buffer 10.688mL. Decoloring in a shaking table at the temperature of 37 ℃ and at the speed of 200r/min, measuring the optical density values of different dyes at the maximum absorption wavelength at 2h, 4h and 6h, and calculating the decoloring rate of the novel laccase Lacc2 to various dyes. The decolorization ratio calculation formula is as follows: r = (A) 0 -A)/A 0 X 100%, where A is the optical density value of the dye at regular sampling, A0 is the optical density value of the initial dye, 3 replicates.
The decolouring rates of the novel laccase Lacc2 to crystal violet, alizarin red, isatin and active black 5 within 6h are respectively 80.8%, 81.6%, 68.5% and 45.85% under the condition of no mediator, and the decolouring effects to crystal violet and alizarin red are better; after the mediator acetosyringone is added into the system, the decolorization rate of the novel laccase Lacc2 on the active black 5 is improved to 84.95% within 6h (figure 5).
Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that various changes, modifications, substitutions and alterations can be made in these embodiments without departing from the principles and spirit of the invention, the scope of which is defined in the appended claims and their equivalents.
Sequence listing
<110> university of Yunnan
<120> a bacterial laccase derived from Astrospiraceae family of elephant intestine and gene thereof
<160> 4
<170> SIPOSequenceListing 1.0
<210> 1
<211> 264
<212> PRT
<213> laccase (Lacc 2)
<400> 1
Met Asn Asp Met Thr Ala Val Ile Lys Thr Ser Ser Lys Ile Lys Ser
1 5 10 15
Pro His Gly Phe Ser Thr Arg Ile Gly Gly Val Ser Thr Gly Ile Phe
20 25 30
Asp Ser Leu Asn Leu Gly Met Asn Arg Gly Asp Asp Glu Asn Leu Val
35 40 45
Lys Glu Asn Trp Arg Arg Phe Met Glu Ala Ser Gly Ile Ser Glu Glu
50 55 60
Lys Phe Val Cys Gly Lys Gln Val His Gly Asn Tyr Val Gln Ile Ala
65 70 75 80
Thr Ser Lys Ile Ala Arg Pro Ala Tyr Gly Pro Gly Trp Met Ala Glu
85 90 95
Ala Asp Gly Tyr Val Thr Asn Glu Pro Gly Leu Pro Leu Ala Val Phe
100 105 110
Thr Ala Asp Cys Val Pro Val Leu Leu Glu Asp Tyr Val Ala Gly Val
115 120 125
Val Ala Ala Val His Cys Gly Trp Arg Ser Thr Val Ala Asp Ile Glu
130 135 140
Lys Glu Thr Ile Glu Lys Met Val Gly Leu Gly Ala Ser Thr Thr Asn
145 150 155 160
Ile Asn Val Ala Ile Gly Pro Ala Ile Cys Asp Lys Cys Phe Gln Val
165 170 175
Gly Ser Glu Val Ile Gly Ala Val Asn Lys Leu Leu Asn Gly Val Glu
180 185 190
Thr Gly Asp Leu Tyr Phe Pro Asp Lys Glu His Asp Asp Lys Phe Tyr
195 200 205
Leu Asn Leu Arg Gly Val Val Lys Arg Arg Phe Met Met Leu Gly Val
210 215 220
Leu Glu Asp Asn Ile Glu Val Ser Arg Glu Cys Thr Met His Gln Pro
225 230 235 240
Thr Glu Tyr Trp Ser His Arg Tyr Thr His Gly Glu Arg Gly Ser Gln
245 250 255
Ala Asn Val Ile Met Leu Ala Arg
260
<210> 2
<211> 795
<212> DNA
<213> laccase Gene (lac 2)
<400> 2
atgaatgata tgacagcagt tattaaaact tcttctaaaa taaagagtcc tcatggcttt 60
tcaacaagaa ttggaggcgt gagtacagga atattcgatt ctcttaatct tggaatgaat 120
agaggcgacg atgaaaatct cgtcaaggaa aactggcgac gattcatgga ggccagtgga 180
ataagtgaag aaaaattcgt gtgtggcaag caggtgcatg gtaattatgt gcagattgct 240
acaagtaaaa tcgcgaggcc tgcatatgga cctggctgga tggcagaggc cgatggctat 300
gttaccaatg aaccagggct tccgctagct gtttttacag ctgattgtgt gccagtgctg 360
ctagaagatt atgtggccgg agttgtcgca gcggtacact gtggatggcg aagtacagtg 420
gctgatatag aaaaggaaac cattgagaag atggtgggac taggcgctag cactactaat 480
attaatgtgg caataggacc agccatatgt gacaagtgct ttcaagttgg tagtgaagtt 540
attggtgccg ttaataaact tcttaatggt gttgaaacag gggatttata ttttccagat 600
aaagagcatg atgataaatt ctatcttaac ctaagagggg tagtaaaaag acggtttatg 660
atgcttggtg tactagaaga caatattgaa gtatccaggg aatgtacaat gcatcaacca 720
actgaatact ggtctcatcg atatacacat ggtgagagag gaagtcaggc caacgttatc 780
atgcttgcta gatag 795
<210> 3
<211> 25
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 3
caattcatga atgatatgac agcag 25
<210> 4
<211> 27
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 4
gtcgacctat ctagcaagca tgataac 27
Claims (5)
1. A bacterial laccase derived from Asian elephant intestinal metagenome is characterized in that the amino acid sequence of the bacterial laccase is shown in SEQ ID NO. 1.
2. The gene encoding the bacterial laccase of claim 1, wherein the nucleotide sequence is shown in SEQ ID No.2.
3. A recombinant plasmid comprising the coding gene of claim 2.
4. A recombinant bacterium comprising the coding gene according to claim 2.
5. Use of the bacterial laccase enzyme of claim 1 for the decolorization of crystal violet, alizarin red, isatin and active black 5.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110906606.1A CN113430182B (en) | 2021-08-09 | 2021-08-09 | Bacterial laccase from Astrospiraceae of elephant intestinal tract and gene thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110906606.1A CN113430182B (en) | 2021-08-09 | 2021-08-09 | Bacterial laccase from Astrospiraceae of elephant intestinal tract and gene thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113430182A CN113430182A (en) | 2021-09-24 |
CN113430182B true CN113430182B (en) | 2023-01-13 |
Family
ID=77763116
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110906606.1A Active CN113430182B (en) | 2021-08-09 | 2021-08-09 | Bacterial laccase from Astrospiraceae of elephant intestinal tract and gene thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113430182B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113430181B (en) * | 2021-08-09 | 2023-01-13 | 云南师范大学 | Bacterial laccase derived from Asian elephant intestinal metagenome and gene thereof |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106434706A (en) * | 2016-11-07 | 2017-02-22 | 吉林大学 | Bacterial laccase gene from bacillus subtilis ZXN4, bacterial laccase and application thereof |
CN106434707A (en) * | 2016-11-07 | 2017-02-22 | 吉林大学 | Bacillus subtilis ZNXH1 sourced bacterial laccase gene, bacterial laccase and application thereof |
CN106947748A (en) * | 2017-04-24 | 2017-07-14 | 南阳师范学院 | A kind of super resistance to Mn2+Bacterial laccase, recombinant vector, recombinant bacterium, enzyme preparation, compound enzyme system and preparation method and application |
CN108103036A (en) * | 2018-01-30 | 2018-06-01 | 天津科技大学 | A kind of novel laccase enzyme and its gene, engineering bacteria, preparation and application |
CN113215179A (en) * | 2021-04-12 | 2021-08-06 | 安徽大学 | Fungal laccase, recombinant pichia pastoris engineering bacteria thereof and application |
CN113430181A (en) * | 2021-08-09 | 2021-09-24 | 云南师范大学 | Bacterial laccase derived from Asian elephant intestinal metagenome and gene thereof |
CN114410595A (en) * | 2021-12-30 | 2022-04-29 | 湖南利尔康生物股份有限公司 | Fungal laccase, preparation method and application thereof |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10154177A1 (en) * | 2001-11-05 | 2003-05-08 | Basf Ag | New nucleic acid encoding variant forms of marker and fine chemical-production proteins, useful for production of fine chemicals, specifically lysine, in microorganisms |
BRPI0516946A (en) * | 2004-09-21 | 2008-09-23 | Ab Enzymes Oy | laccase enzymes and their uses |
JP2006158252A (en) * | 2004-12-06 | 2006-06-22 | National Institute Of Advanced Industrial & Technology | Heat-resistant laccase and its manufacturing method |
WO2007068248A2 (en) * | 2005-12-12 | 2007-06-21 | Manurox Aps | Method and facility for manufacturing a natural fertilizer |
CN101067117A (en) * | 2007-04-30 | 2007-11-07 | 云南师范大学 | Process of producing heat resistant xylanase with genetically recombinant Pichia yeast |
CN101113421B (en) * | 2007-06-22 | 2010-05-19 | 云南师范大学 | Generation bacterium of heat-stable phytase |
TW200948964A (en) * | 2008-04-17 | 2009-12-01 | Novozymes As | Laccase variants |
US8414660B2 (en) * | 2009-05-08 | 2013-04-09 | University Of Florida Research Foundation, Inc. | Haloferax volcanii laccase and variants and fragments thereof |
JP2014504151A (en) * | 2010-11-08 | 2014-02-20 | ディノベ | Laccase and its use |
EP2522690A1 (en) * | 2011-03-24 | 2012-11-14 | Annikki GmbH | Method for manufacturing lignin derivatives |
KR101406933B1 (en) * | 2011-09-02 | 2014-06-12 | 동국대학교 산학협력단 | New enzymatic time-temperature integrator using laccase |
US9725770B2 (en) * | 2012-03-06 | 2017-08-08 | The Regents Of The University Of California | Methods and compositions for identification of source of microbial contamination in a sample |
US20170226503A1 (en) * | 2014-02-06 | 2017-08-10 | MetaMixis Biologics, Inc. | Methods for Sequential Screening with Co-Culture Based Detection of Metagenomic Elements Conferring Heterologous Metabolite Secretion |
US10258065B2 (en) * | 2014-07-10 | 2019-04-16 | Novozymes A/S | Polypeptides having xylanase activity and polynucleotides encoding same |
US20170303548A1 (en) * | 2014-08-20 | 2017-10-26 | Novozymes A/S | GH5 Xylanase for Dough Dryness |
CN106047827A (en) * | 2016-07-25 | 2016-10-26 | 南京林业大学 | Laccase CotA and application thereof |
WO2019043088A1 (en) * | 2017-08-31 | 2019-03-07 | Novozymes A/S | Polypeptides having d-psicose 3-epimerase activity and polynucleotides encoding same |
CN108374000A (en) * | 2018-03-01 | 2018-08-07 | 华南理工大学 | A kind of Laccase mutant and the preparation method and application thereof improving dye decolored efficiency |
US20220010305A1 (en) * | 2018-10-31 | 2022-01-13 | Novozymes A/S | Genome Editing by Guided Endonuclease and Single-stranded Oligonucleotide |
US20220275354A1 (en) * | 2019-05-15 | 2022-09-01 | Novozymes A/S | TEMPERATURE-SENSITIVE RNA- Guided Endonuclease |
CN110218708B (en) * | 2019-06-20 | 2021-08-27 | 天津科技大学 | Bacterial laccase and gene, preparation method and application thereof |
CN110295182A (en) * | 2019-07-04 | 2019-10-01 | 山东省农业科学院生物技术研究中心 | A kind of laccase gene slr1573 derived from cytoalgae and the application in dye decolored |
-
2021
- 2021-08-09 CN CN202110906606.1A patent/CN113430182B/en active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106434706A (en) * | 2016-11-07 | 2017-02-22 | 吉林大学 | Bacterial laccase gene from bacillus subtilis ZXN4, bacterial laccase and application thereof |
CN106434707A (en) * | 2016-11-07 | 2017-02-22 | 吉林大学 | Bacillus subtilis ZNXH1 sourced bacterial laccase gene, bacterial laccase and application thereof |
CN106947748A (en) * | 2017-04-24 | 2017-07-14 | 南阳师范学院 | A kind of super resistance to Mn2+Bacterial laccase, recombinant vector, recombinant bacterium, enzyme preparation, compound enzyme system and preparation method and application |
CN108103036A (en) * | 2018-01-30 | 2018-06-01 | 天津科技大学 | A kind of novel laccase enzyme and its gene, engineering bacteria, preparation and application |
CN113215179A (en) * | 2021-04-12 | 2021-08-06 | 安徽大学 | Fungal laccase, recombinant pichia pastoris engineering bacteria thereof and application |
CN113430181A (en) * | 2021-08-09 | 2021-09-24 | 云南师范大学 | Bacterial laccase derived from Asian elephant intestinal metagenome and gene thereof |
CN114410595A (en) * | 2021-12-30 | 2022-04-29 | 湖南利尔康生物股份有限公司 | Fungal laccase, preparation method and application thereof |
Non-Patent Citations (1)
Title |
---|
基于高通量测序的宏基因组学技术在动物胃肠道微生物方面的研究进展;吴森等;《生物技术进展》;20150325(第02期);第7-14页 * |
Also Published As
Publication number | Publication date |
---|---|
CN113430182A (en) | 2021-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110218708B (en) | Bacterial laccase and gene, preparation method and application thereof | |
CN111718915B (en) | Nicotinamide phosphoribosyl transferase mutant, recombinant expression vector and recombinant bacterium containing mutant and application | |
CN112725309B (en) | Low-temperature inulase exo-mutant MutP126R stable at medium temperature | |
US10787651B2 (en) | Bradyrhizobium monooxygenase and use thereof for preparation of chiral sulfoxide | |
CN112813054A (en) | Inulase mutant MutS117N with changed low-temperature salt tolerance and application thereof | |
CN112725305A (en) | Thermohaline-sensitive inulase mutant MutY119D and preparation method thereof | |
CN110607319B (en) | Expression vector suitable for bacillus subtilis secretion expression protein and application | |
WO2022134236A1 (en) | Alkaline protease mutant, gene thereof, engineering bacteria thereof, preparation method therefor and use thereof | |
CN113430182B (en) | Bacterial laccase from Astrospiraceae of elephant intestinal tract and gene thereof | |
CN113430181B (en) | Bacterial laccase derived from Asian elephant intestinal metagenome and gene thereof | |
CN104531637A (en) | Beta-glucosaccharase, beta-glucosaccharase mutant and application | |
CN114181918A (en) | Omega-transaminase mutant obtained by DNA synthesis shuffling and combined mutation and application thereof | |
CN114591935A (en) | Protease mutant BLAPR3 with improved heat stability and coding gene and application thereof | |
CN113913400A (en) | L-sorbosone dehydrogenase mutant with improved catalytic activity | |
CN114672525A (en) | Biosynthesis method and application of N-acetyl-5-methoxytryptamine | |
CN117625504A (en) | Engineering bacterium combined into 6,6' -dibromo indigo as well as preparation method and application thereof | |
CN112921043A (en) | Mutant nucleic acid, expression vector, laccase mutant with high specific activity and preparation method thereof | |
CN115717131A (en) | Recombinant tyrosinase mutant and application thereof | |
CN115960879A (en) | High-throughput screening method of D-psicose 3-epimerase mutant library and obtained mutant | |
CN114395571B (en) | Phaeodactylum tricornutum ZEP1 gene, protein and application | |
WO2018171400A1 (en) | Bacterium for engineering acarbose, preparation method therefor, and application thereof | |
CN115433721A (en) | Carbonyl reductase mutant and application thereof | |
CN110862952A (en) | 5-aminolevulinic acid production strain and construction method and application thereof | |
CN115716868B (en) | Transcription factor MrPigB mutant and application thereof | |
CN113862239B (en) | Mongolian astragalus disease course related protein mutant with improved nuclease activity and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
OL01 | Intention to license declared | ||
OL01 | Intention to license declared |